TP53 and B-cell chronic lymphocytic leukemia: Thus, SAS employment in association with PRIMA-1Met could further increase the intracellular oxidative stress and sensitize CLL cells carrying mutant p53 or expressing a wt p53 but experiencing a therapy-resistant phenotype.